KGET - CaliPharms, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.39M
Enterprise Value 3606.7k
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)12.34
Price/Book (mrq)N/A
Enterprise Value/Revenue 35.39
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 2.25
52-Week Change 3-99.00%
S&P500 52-Week Change 37.40%
52 Week High 30.0100
52 Week Low 30.0000
50-Day Moving Average 30.0001
200-Day Moving Average 30.0001

Share Statistics

Avg Vol (3 month) 32.42M
Avg Vol (10 day) 3748.37k
Shares Outstanding 513.88B
Float N/A
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22000/1
Last Split Date 3Aug 28, 2008

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2013
Most Recent Quarter (mrq)Sep 30, 2014

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-689.66%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)112.47k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-6.31M
Diluted EPS (ttm)-0.0020
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.16k
Total Cash Per Share (mrq)0
Total Debt (mrq)222.55k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.00
Book Value Per Share (mrq)-0.00

Cash Flow Statement

Operating Cash Flow (ttm)-721.44k
Levered Free Cash Flow (ttm)N/A